In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates. 2012

Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium. filip.boyen@ugent.be

BACKGROUND Meticillin-resistant Staphylococcus aureus (MRSA) and meticillin-resistant Staphylococcus pseudintermedius (MRSP) infections are increasingly reported in dogs, and these bacteria may be isolated from ear infections. OBJECTIVE The main aim of the present study was to investigate the in vitro antimicrobial activity of miconazole, polymyxin B and a combination of both against 24 canine MRSA and 50 canine MRSP isolates. The minimal inhibitory concentration (MIC) values of 12 other antimicrobial agents were also determined. METHODS All MIC values were determined according to a broth microdilution assay. RESULTS Acquired resistance was found to all tested agents, except for linezolid, miconazole and polymyxin B. The MIC values for miconazole and polymyxin B against MRSA were in the range of 4-8 and 8-64 μg/mL, respectively, while the MIC values for miconazole and polymyxin B against MRSP were in the range of 1-2 and 0.25-4 μg/mL, respectively. Using a combination of miconazole and polymyxin B, there was no evidence for enhanced in vitro activity of the combination (i.e. synergy) of both products. Nevertheless, MIC(90) values of the combination of these antimicrobial agents and of a commercial product containing both agents were at least 1000 times lower than the concentration present in the commercial product. CONCLUSIONS These results indicate that the topical use of a combination of miconazole and polymyxin B in a 43.5:1 ratio may have potential for the treatment of MRSA-mediated and MRSP-associated otitis externa in dogs.

UI MeSH Term Description Entries
D008825 Miconazole An imidazole antifungal agent that is used topically and by intravenous infusion. Brentan,Dactarin,Miconasil Nitrate,Miconazole Nitrate,Monistat,R-14,889,Nitrate, Miconasil,Nitrate, Miconazole,R 14,889,R14,889
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013207 Staphylococcal Skin Infections Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS. Skin Diseases, Staphylococcal,Infections, Staphylococcal Skin,Skin Infections, Staphylococcal,Staphylococcal Diseases, Skin,Staphylococcal Infections, Skin,Staphylococcal Skin Diseases
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D016106 Methicillin Resistance Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative. Methicillin-Resistant,Methicillin Resistant,Resistance, Methicillin

Related Publications

Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
October 2012, Veterinary dermatology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
October 2016, Veterinary dermatology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
February 2018, Veterinary dermatology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
March 2012, Veterinary microbiology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
September 2014, Journal of medical microbiology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
June 2014, Journal of global antimicrobial resistance,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
January 1993, Microbiology and immunology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
November 2017, Antibiotics (Basel, Switzerland),
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
October 2016, Journal of medical microbiology,
Filip Boyen, and Koen M H W Verstappen, and Manuelle De Bock, and Birgitta Duim, and J Scott Weese, and Stefan Schwarz, and Freddy Haesebrouck, and Jaap A Wagenaar
February 2023, Veterinary dermatology,
Copied contents to your clipboard!